JPMorgan Chase & Co’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $860K | Sell |
356,882
-321,305
| -47% | -$774K | ﹤0.01% | 3809 |
|
|
2025
Q1 | $1.5M | Sell |
678,187
-3,572,469
| -84% | -$7.9M | ﹤0.01% | 3428 |
|
|
2024
Q4 | $23.2M | Buy |
4,250,656
+200,411
| +5% | +$1.09M | ﹤0.01% | 1637 |
|
|
2024
Q3 | $33.7M | Buy |
4,050,245
+3,731,924
| +1,172% | +$31M | ﹤0.01% | 1398 |
|
|
2024
Q2 | $2.28M | Sell |
318,321
-158,451
| -33% | -$1.13M | ﹤0.01% | 3007 |
|
|
2024
Q1 | $4.13M | Buy |
476,772
+101,204
| +27% | +$877K | ﹤0.01% | 2685 |
|
|
2023
Q4 | $2.46M | Buy |
375,568
+55,828
| +17% | +$366K | ﹤0.01% | 3015 |
|
|
2023
Q3 | $3.2M | Sell |
319,740
-8,103
| -2% | -$81K | ﹤0.01% | 2708 |
|
|
2023
Q2 | $4.08M | Sell |
327,843
-3,562,634
| -92% | -$44.3M | ﹤0.01% | 2631 |
|
|
2023
Q1 | $54.5M | Sell |
3,890,477
-20,555
| -0.5% | -$288K | 0.01% | 977 |
|
|
2022
Q4 | $56M | Buy |
3,911,032
+326,260
| +9% | +$4.67M | 0.01% | 937 |
|
|
2022
Q3 | $91.5M | Buy |
3,584,772
+54,211
| +2% | +$1.38M | 0.01% | 713 |
|
|
2022
Q2 | $100M | Buy |
3,530,561
+135,961
| +4% | +$3.86M | 0.01% | 704 |
|
|
2022
Q1 | $120M | Sell |
3,394,600
-116,607
| -3% | -$4.11M | 0.01% | 725 |
|
|
2021
Q4 | $147M | Sell |
3,511,207
-455,348
| -11% | -$19.1M | 0.02% | 652 |
|
|
2021
Q3 | $195M | Sell |
3,966,555
-915,396
| -19% | -$44.9M | 0.02% | 548 |
|
|
2021
Q2 | $204M | Buy |
4,881,951
+498,314
| +11% | +$20.8M | 0.02% | 561 |
|
|
2021
Q1 | $156M | Buy |
4,383,637
+242,648
| +6% | +$8.65M | 0.02% | 616 |
|
|
2020
Q4 | $116M | Buy |
+4,140,989
| New | +$116M | 0.02% | 672 |
|